Skip to main content

View Resource

Published

Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anticancer therapy (SACT).
McLean J. BMJ Quality & Safety 2025;34(11):768-780.
[Disparities have been identified in many aspects of the cancer care pathway for people from minority ethnic groups (MEGs). Adherence to systemic anticancer therapies (SACTs) has been shown to impact morbidity and mortality, and therefore, inequitable experiences can have a detrimental effect on outcomes. The aim of this review was to identify interventions that focused on improving the experiences and clinical outcomes in people from MEG receiving SACT treatments.]
Available with an NHS OpenAthens password for eligible users
More details
Age Groups
Adults
Conditions and Lifestyle Factors
Cancer
Race & Ethnicity
Settings
Hospital Ward
Outpatient Department
Staff Groups
Medic
Non-Clinical Professional
Nurse Specialist
Public Health Doctor
Public Health Specialist